期刊文献+

基于个案管理的延伸护理服务在晚期胃癌化疗患者中的应用效果 被引量:3

下载PDF
导出
摘要 目的观察基于个案管理的延伸护理服务在晚期胃癌化疗患者中的应用效果。方法选取2016年1月至2018年9月舞阳县人民医院收治的66例晚期胃癌化疗患者,按照入院顺序分为对照组和观察组,各33例。对照组接受常规护理干预,观察组在对照组基础上接受基于个案管理的延伸护理服务。比较两组治疗依从性、汉密尔顿焦虑量表(HAMA)评分、护理满意度。结果治疗后观察组依从性(93.94%)高于对照组(75.76%)(P<0.05)。观察组干预后HAMA评分低于对照组,护理满意度评分高于对照组(均P<0.05)。结论基于个案管理的延伸护理服务应用于晚期胃癌化疗患者可提高治疗依从性,改善焦虑情绪,提高患者护理满意度。
作者 李晓丹
出处 《河南医学研究》 CAS 2020年第4期753-755,共3页 Henan Medical Research
  • 相关文献

参考文献3

二级参考文献54

  • 1万崇华,孟琼,汤学良,张灿珍,罗家洪,张晓磐.癌症患者生命质量测定量表FACT-G中文版评介[J].实用肿瘤杂志,2006,21(1):77-80. 被引量:411
  • 2Coleman E A,Boult C,American Geriatrics Society Health Care Systems Committee.Improving the quality of transitional care for persons with complex care needs[J].J Am Geriatr Soc,2003,51(4):556-557.
  • 3Prvu Bettger J,Alexander K P,Dolor R J,et al.Transi-tional care after hospitalization for acute stroke or myo-cardial infarction:a systematic review[J].Ann Intern Med,2012,157(6):407-416.
  • 4Brenner H, Rothenbacher D, Arndt V, et al. Epidemiology of stomach cancer[J]. Methods Mol Biol, 2009, 472 (5450):1567-1568.
  • 5Jemal A, Siegel R, Xu J, et al.Cancer statistics[J]. JAMA, 2013, 310 (9):982.
  • 6Wagner AD, Grothe W, Haerting J, et al. Chemotherapy in Ad- vanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggresate Data[J]. Journal of Clinical Oncology, 2006, 24 (18):2903-2909.
  • 7Ye JX, Liu AO., Ge LY, et al. Effectiveness and safety profile of S-l-based chemotherapy compared with capecitabine-based che- motherapy for advanced gastric and colorectal cancer: A me- ta-analysis[J]. Experimental and Therapeutic Medicine, 2014, 7(5): 1271-1278.
  • 8Ajani JA, Buyse M, Lichinitser M, et al. Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesopha- geal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study[J]. European Journal of Cancer, 2013, 49(17): 3616-3624.
  • 9Boku N, Yamamoto S, Fukuda H, et al. Fluorouracil versus combina- tion of irinotecan plus cisplatin versus S-1 in metastatic gastric can- cer: a randomised phase 3 study[J]. Lancet Oncol, 2009, 10(11): 1063-1069.
  • 10Lee JL, Kang YK, Kan8 H J, et al. A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer[J]. Br J Cancer, 2008, 99(4):584-590.

共引文献109

同被引文献41

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部